These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16183034)

  • 1. Hypercalcemia produced by parathyroid hormone suppresses experimental autoimmune encephalomyelitis in female but not male mice.
    Meehan TF; Vanhooke J; Prahl J; Deluca HF
    Arch Biochem Biophys; 2005 Oct; 442(2):214-21. PubMed ID: 16183034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1α,24(S)(OH)2D2 normalizes bone morphology and serum parathyroid hormone without hypercalcemia in 25-hydroxyvitamin D-1-hydroxylase (CYP27B1)-deficient mice, an animal model of vitamin D deficiency with secondary hyperparathyroidism.
    St-Arnaud R; Arabian A; Yu VW; Akhouayri O; Knutson JC; Strugnell SA
    J Endocrinol Invest; 2008 Aug; 31(8):711-7. PubMed ID: 18852532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium.
    Bland R; Walker EA; Hughes SV; Stewart PM; Hewison M
    Endocrinology; 1999 May; 140(5):2027-34. PubMed ID: 10218951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of 1,25-dihydroxyvitamin D
    Nishikawa M; Yasuda K; Takamatsu M; Abe K; Nakagawa K; Tsugawa N; Hirota Y; Tanaka K; Yamashita S; Ikushiro S; Suda T; Okano T; Sakaki T
    J Steroid Biochem Mol Biol; 2019 Jan; 185():71-79. PubMed ID: 30031146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive and negative regulations of the renal 25-hydroxyvitamin D3 1alpha-hydroxylase gene by parathyroid hormone, calcitonin, and 1alpha,25(OH)2D3 in intact animals.
    Murayama A; Takeyama K; Kitanaka S; Kodera Y; Kawaguchi Y; Hosoya T; Kato S
    Endocrinology; 1999 May; 140(5):2224-31. PubMed ID: 10218975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
    Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The absence of 25-hydroxyvitamin D3-1α-hydroxylase potentiates the suppression of EAE in mice by ultraviolet light.
    Wang Y; Marling SJ; Martino VM; Prahl JM; Deluca HF
    J Steroid Biochem Mol Biol; 2016 Oct; 163():98-102. PubMed ID: 27108944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The calcitonin/calcitonin gene related peptide-alpha gene is not required for 1alpha,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis.
    Becklund BR; James BJ; Gagel RF; DeLuca HF
    Arch Biochem Biophys; 2009 Aug; 488(2):105-8. PubMed ID: 19563774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal parathyroid hormone stimulation of 25-hydroxyvitamin D-1 alpha-hydroxylase activity in the hypophosphatemic mouse. Evidence for a generalized defect of vitamin D metabolism.
    Nesbitt T; Drezner MK; Lobaugh B
    J Clin Invest; 1986 Jan; 77(1):181-7. PubMed ID: 3753708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous PTH-related protein and PTH improve mineral and skeletal status in 25-hydroxyvitamin D-1alpha-hydroxylase and PTH double knockout mice.
    Xue Y; Zhang Z; Karaplis AC; Hendy GN; Goltzman D; Miao D
    J Bone Miner Res; 2005 Oct; 20(10):1766-77. PubMed ID: 16160734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of 25-hydroxyvitamin D-1alpha-hydroxylase in dysgerminomas: a novel form of humoral hypercalcemia of malignancy.
    Evans KN; Taylor H; Zehnder D; Kilby MD; Bulmer JN; Shah F; Adams JS; Hewison M
    Am J Pathol; 2004 Sep; 165(3):807-13. PubMed ID: 15331405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells.
    Ritter CS; Armbrecht HJ; Slatopolsky E; Brown AJ
    Kidney Int; 2006 Aug; 70(4):654-9. PubMed ID: 16807549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression by parathyroid hormone and 1,25-dihydroxyvitamin D3.
    Brenza HL; DeLuca HF
    Arch Biochem Biophys; 2000 Sep; 381(1):143-52. PubMed ID: 11019830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of dietary vitamin D3 on the circulating concentration of its active metabolites in the chick and rat.
    Hughes MR; Baylink DJ; Gonnerman WA; Toverud SU; Ramp WK; Haussler MR
    Endocrinology; 1977 Mar; 100(3):799-806. PubMed ID: 233823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conflicting actions of parathyroid hormone-related protein and serum calcium as regulators of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase expression in a nude rat model of humoral hypercalcemia of malignancy.
    Michigami T; Yamato H; Suzuki H; Nagai-Itagaki Y; Sato K; Ozono K
    J Endocrinol; 2001 Nov; 171(2):249-57. PubMed ID: 11691644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hypercalcemia-producing tumor on 1,25(OH)2D3 biosynthesis in athymic mice.
    Kukreja SC; York PA; Nalbantian-Brandt C; Shevrin DH; Favus MJ
    Am J Physiol; 1989 Feb; 256(2 Pt 1):E309-14. PubMed ID: 2919669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25-dihydroxyvitamin D3 as well as its analogue OCT lower blood calcium through inhibition of bone resorption in hypercalcemic rats with continuous parathyroid hormone-related peptide infusion.
    Endo K; Katsumata K; Hirata M; Masaki T; Kubodera N; Nakamura T; Ikeda K; Ogata E
    J Bone Miner Res; 2000 Jan; 15(1):175-81. PubMed ID: 10646127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New 19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 analogs strongly stimulate osteoclast formation both in vivo and in vitro.
    Sato M; Nakamichi Y; Nakamura M; Sato N; Ninomiya T; Muto A; Nakamura H; Ozawa H; Iwasaki Y; Kobayashi E; Shimizu M; DeLuca HF; Takahashi N; Udagawa N
    Bone; 2007 Feb; 40(2):293-304. PubMed ID: 17070129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.